(Q40093521)

17 September 2017

title

Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival (English)

1 reference

17 September 2017

1 reference

D Srinivasan

1 reference

17 September 2017

J T Sims

series ordinal

1 reference

17 September 2017

R Plattner

series ordinal

1 reference

17 September 2017

language of work or name

English

0 references

publication date

13 August 2007

1 reference

17 September 2017

1 reference

17 September 2017

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

1095-1105

1 reference

Poly(ADP-ribose). The most elaborate metabolite of NAD+.

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

ErbB receptors: directing key signaling networks throughout life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Tyrosine kinase signalling in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Cell sorting but not serum starvation is effective for SV40 human corneal epithelial cell cycle synchronization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

PI3K/Akt/mTOR pathway as a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

The Abl family kinases: mechanisms of regulation and signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

The role of mitogen-activated protein (MAP) kinase in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Prognostic value of proliferation in invasive breast cancer: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Prognostic role of p27Kip1 and apoptosis in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210714

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210714

1 reference

Dimensions Publication ID

17 September 2017

1019183858

0 references

1 reference